Blueprint Medicines | 4:持股變動聲明-高管 Landsittel Michael
Blueprint Medicines | 4:持股變動聲明-高管 Landsittel Michael
Blueprint Medicines | 4:持股變動聲明-高管 Hurley Ariel
Blueprint Medicines | SC 13G/A:超過5%持股股東披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(10.2%)
Blueprint Medicines | 4:持股變動聲明-高管 Landsittel Michael
Blueprint Medicines | 4:持股變動聲明-董事 Albers Jeffrey W.
Blueprint Medicines | 4:持股變動聲明-董事 Albers Jeffrey W.
Blueprint Medicines | 4:持股變動聲明-高管 Landsittel Michael
Blueprint Medicines | 4:持股變動聲明-高管 Hurley Ariel
Blueprint Medicines | 4:持股變動聲明-高管 Lee Philina
Blueprint Medicines | 4:持股變動聲明-高管 Hewes L. Becker
Blueprint Medicines | 4:持股變動聲明-高管 Durso-Bumpus Debra
Blueprint Medicines | 4:持股變動聲明-高管 Haviland Kate
Blueprint Medicines | 4:持股變動聲明-高管 Lee Philina
Blueprint Medicines | 4:持股變動聲明-高管 Murray Christopher K.
Blueprint Medicines | 4:持股變動聲明-高管 Landsittel Michael
Blueprint Medicines | 4:持股變動聲明-高管 Rossi Christina
Blueprint Medicines | 4:持股變動聲明-高管 Namouni Fouad
Blueprint Medicines | 4:持股變動聲明-高管 Carter Percy H.
Blueprint Medicines | 4:持股變動聲明-高管 McCain Tracey L
暫無數據